Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease: A Pilot Chemoprevention Trial

Trial Profile

Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease: A Pilot Chemoprevention Trial

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Jan 2016

At a glance

  • Drugs Exemestane (Primary) ; Raloxifene (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Sep 2008 Status changed from active, no longer recruiting to completed based on publication of final results.
    • 01 Sep 2008 Results published in Breast Cancer Research and Treatment.
    • 14 Dec 2007 The expected completion date for this trial is now 1 Jul 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top